Lou Basenese’s Biotech Breakout Alert
by nrggate | November 18, 2020 2:16 pm
I just heard Lou’s pitch for his Biotech Breakout Alert. He claims to be tracking the FDA[1] Form 1571 regarding the status of clinical trials. Has anyone subscribed to this or any of his previous publications? What has been the quality of his recommendations?
Endnotes:
- FDA: https://www.stockgumshoe.com/tag/fda/
Source URL: https://www.stockgumshoe.com/2020/11/microblog-lou-baseneses-biotech-breakout-alert/
No clue on that pitch or Lou’s latest new pitch on Elon Musk’s taking over the internet.
Cable tv to be obsolete with Elon’s new TV Tesla????
. You must buy in to get the new stock before December 31. Maybe Travis can find out for us.
After I posted my earlier request, I did my best Travis imitation (with all due respect, Travis) and sussed all three symbols from LOU BASENESE’S BIOTECH BREAKOUT ALERT teases. I believe Lou is using ClinicalTrials.gov as the “public database” that he mentions. My researched guesses are: (1) “CG-806 on Dec 5” refers to Aptose Biosciences (Ticker: APTO). Both of its drugs CG-806 and APTO-253 are providing an update at the American Society of Hematology (ASH) 2020 annual meeting on Dec 5-8, 2020. (2) “KO-539 on Dec 8” refers to Kura Oncology’s (Ticker: KURA) drug that presents at the same ASH 2020 meeting as Aptose. (3) “TransCon PTH on Dec 31” refers to Ascendis Pharma (Ticker: ASND). TransCon stands for its proprietary technology “transient conjugation.” PTH is one of its drugs designated an “orphan.” However, I haven’t determined the significance of Dec 31. I know other details like the names of principal investigators and NCT numbers if anyone wants them. I don’t usually invest in BioMed, but I might put a small amount on these soon.
@NRRGATE I did do some investigating trying to figure where these delivery dates came from looks like he is banking on the ASH meeting. Not sure who all is there but it must be some big money ? I basically took screen shots of all his slides. Cross reference was simple. Most of these companies are on the NQ one is a small cap BPSR Organicell Regenr Medicine
Im watching APTO like a HAWK if indeed it does inflate on 12-05-20 Im in and will be trying to figure out LB angle. Very Interesting. He lost me at “im only selecting a select few people”
APTO (NQ) = Aptose Biosciences Delivery Date 12-05-20
Drug CG806 blood cancer treatment
Currently Trading at $6.13 Nov 25, 2020 Trend Trader Daily CG806
https://clinicaltrials.gov/ct2/show/NCT03893682
KURA (NQ) = Kura Oncology Delivery Date 12-08-2020 DRUG KO539 Acute Myeloid Leukemia
Currently Trading at $35 Nov 25, 2020
https://clinicaltrials.gov/ct2/show/NCT04384445 Acute Myeloid Leukemia
ASND (NQ) = Ascendis Pharma A/S Delivery Date 12-31-2020 DRUG Transcon PTH
Currently Trading at $162.15 Nov 25, 2020
https://clinicaltrials.gov/ct2/show/NCT04009291 Thyroid Treatment
CNST (NQ) = Constellation Pharmaceuticals Drug CPI-0610
Currently Trading at $25.45 Nov 25, 2020 Ruxolitinib in patients with Myelofibrosis
https://clinicaltrials.gov/ct2/show/NCT0215885
MCRB (NQ) = Seres Therapeutics Drug SER – 109
Currently trading at 29.39 Nov. 25, 2020
https://clinicaltrials.gov/ct2/history/NCT03183128?V_3=View
CCXI (NQ) = ChemoCentryx Drug Avacopan for Acne
Currently trading at $54.00
https://clinicaltrials.gov/ct2/show/NCT03852472
KRTX (NQ)= Karuna Pharmaceuticals KarXT in adult subjects diagnosed with DSM-5 schizophrenia
Currently trading at $97.99
KarXT in adult subjects diagnosed with DSM-5 schizophrenia
Thanks for your research and additional insights.
Have not heard about CNST, MCRB, CCXI, KTRX or BPSR with the presentation. Found APTO, KURA, and ASND on my own. If you don’t mind my asking where did you come up with the first 5? Was it his presentation on Nov 18th or a later date? I looked up the codes too but did not see codes for those 5.